Dapagliflozin Completed Phase 1 Trials for Type 2 Diabetes

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00908271
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
NCT00842556
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
NCT02060201
Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)
NCT01135446
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects
NCT00839683
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
NCT01002807
Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State
NCT01055652
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
NCT01662999
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants